Navigation Links
Vermillion Reports First Quarter 2012 Results
Date:5/15/2012

AUSTIN, Texas, May 15, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, reported financial and operational results for the first quarter ended March 31, 2012.

Q1 2012 Operational Highlights

  • In Q1, the volume of OVA1®, the company's flagship diagnostic test designed to help differentiate benign from malignant ovarian masses, was generally in line with the forecast set by management for the quarter and demonstrated an increase of 28% to 3,952 from the same year-ago quarter.
  • Received a Category 1 Current Procedural Terminology (CPT®) code approval from the American Medical Association (AMA) CPT Panel for OVA1. The company expects this major endorsement to help streamline claims processing and accelerate further coverage and adoption by private payers.
  • Expanded payer coverage for OVA1 with the addition of Excellus BCBS (3.3 million lives), BCBS LA (1.1 million lives), and Wellmark South Dakota and Wellmark Iowa (2.1 million lives). Currently, there are 26 independent Blue Cross Blue Shield plans representing in excess of 42 million lives. Including Medicare and other regional plans, total coverage for OVA1 is estimated to be approximately 89 million lives.
  • In January, the Department of Defense added OVA1 to their contract, giving more than 45 military medical centers in the U.S. and numerous military medical clinics and facilities around the world access to OVA1 for the first time. This provides coverage to approximately 1.4 million uniformed service members.
  • Strengthened the company's patent portfolio with two notices of allowance for patents, including platelet biomarkers for cancer and methods for diagnosing ovarian cancer.
  • Settled Bio-Rad litigation and returned $1.1 million in escrow funds to Vermillion in April 2012.
  • Settled Molecular Anal
    '/>"/>

  • SOURCE Vermillion, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Vermillion Reports Fourth Quarter and Full Year 2011 Results
    2. Vermillion Sharpens Focus and Streamlines Operations in 2012
    3. Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
    4. Vermillion Reports Results for the Second Quarter 2011
    5. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
    6. Vermillion Announces Joining Russell Microcap® Index
    7. Vermillion Announces Notice of Allowance for Alzheimer Patent
    8. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
    9. Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011
    10. Stephens Initiates Coverage on Vermillion
    11. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... Memphis, TENN (PRWEB) December 22, 2014 ... with Donor Egg Bank USA , a network ... the country. Through this partnership, patients have fast access ... for in vitro fertilization, IVF . Fertility Associates of ... to offer this fertility treatment option. , Dr. ...
    (Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
    (Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
    (Date:12/19/2014)... 19, 2014 Bina Technologies, Inc. (Bina, ... they have been acquired by Roche (SIX: RO, ROG; ... held company that provides a big data platform for ... data for the academic and translational research markets.  Bina ... will continue to focus on development of their innovative ...
    Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
    ... week ago, 67 companies were nervously introducing their products ... executives, early adopters, and eager media. , ,DEMOfall 2006 ... flawless. John Patrick's FutureScan panels were smart. The buzz ... was glitch-free. , ,The DEMOgods smiled upon us ...
    ... including one from California, to stem cell patents held ... lack merit and underscore the need for serious patent ... of challenging patents, such as those held by WARF, ... the United States Patent and Trademark Office ...
    ... of a directive to provide $5 million in state funding ... state will provide $1 million in state loans and grants ... , ,Thomson, the University of Wisconsin-Madison professor who ... Stem Cell Products, Inc., and Cellular Dynamics International . ...
    Cached Biology Technology:Basking (briefly) in the DEMOfall 2006 glow 2WARF challenges show need for patent reform 2WARF challenges show need for patent reform 3WARF challenges show need for patent reform 4State puts up $1 million for James Thomson's new stem cell startup 2State puts up $1 million for James Thomson's new stem cell startup 3
    (Date:12/10/2014)... SAN DIEGO , Dec. 9, 2014 ... and collaboration catalyst that provides the connective tissue that ... by enabling them to easily share client-level information; earned ... Foundation to expand to organizations serving seniors aging in ... San Diego" partner on December 11 th 4-6p. ...
    (Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
    (Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
    Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
    ... have shown great success in treating many patients with lung, ... resistance means that many other patients do not respond, and ... A new study from MIT reveals that much of ... cells to circumvent the effects of ErbB inhibitors, allowing them ...
    ... and the Academy of Science of South Africa are set ... cooperation agreement signed in Pretoria by Leopoldina President Professor Jrg ... Africa, Professor Daya Reddy. The Leopoldina has had ... South Africa for many years, and the 2012/2013 German-South African ...
    ... Ariz. Improved diagnosis for people afflicted with carpal tunnel ... hand is the goal of a research collaboration led ... a Mayo Clinic physician. Marco Santello and Mark Ross ... for Regenerative Medicine to advance their effort to quantify the ...
    Cached Biology News:Why tumors become drug-resistant 2Why tumors become drug-resistant 3Leopoldina signs cooperation agreement with the Academy of Science of South Africa 2ASU-Mayo research project targets carpal tunnel syndrome diagnosis 2
    ...
    Request Info...
    LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
    The FliTrx Panning Kit is designed to simplify panning for protein-protein interactions with the FliTrx Random Peptide Display Library or the pFliTrx Peptide Display Vector....
    Biology Products: